Order Article Reprints

Huntington KE, Carlsen L, So E-Y, Piesche M, Liang O, El-Deiry WS. Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity. Pharmaceuticals. 2022; 15(5):618. https://doi.org/10.3390/ph15050618

Huntington, Kelsey E., Lindsey Carlsen, Eui-Young So, Matthias Piesche, Olin Liang, and Wafik S. El-Deiry. 2022. "Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity" Pharmaceuticals 15, no. 5: 618. https://doi.org/10.3390/ph15050618

Huntington, K. E., Carlsen, L., So, E.-Y., Piesche, M., Liang, O., & El-Deiry, W. S. (2022). Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity. Pharmaceuticals, 15(5), 618. https://doi.org/10.3390/ph15050618